Nightingale releases R5 of its next generation cloud-based Electronic Health Record platform

NightingaleEHR platform has achieved another major functionality and development milestone with the release of version R5 which addresses the needs of US clients

MARKHAM, ON, April 2, 2014 /CNW/ - Nightingale Informatix Corporation ("Nightingale" or the "Company") (TSX-V: NGH), a cloud-based provider of electronic health record (EHR) software and related services, today announced the availability of the next release (R5) of its next-generation EHR platform - NightingaleEHR

"This is Nightingale's 5th production release of NightingaleEHR," said Sam Chebib, President & CEO of Nightingale.  "It represents a significant milestone in our journey towards a game-changing EHR that is intuitive, browser agnostic, robust and secure. We have been hard at work designing our new product, in collaboration with our clients, to be so easy-to-use that almost no training is needed."

Nightingale has invested significant time and resources into NightingaleEHR. NightingaleEHR has been built and designed based on the Nexia technology platform and has been designed around five key principles: (1) Device and browser agnostic; (2) Highly intuitive with zero-based training needs; (3) Role based and workflow driven; (4) Highly interoperable; and (5) Multi-lingual support.

"R5 of NightingaleEHR is aimed at addressing the needs of our US clients," said Trevor Henderson, EVP of Operations at Nightingale. "This release introduces the new Billing module and is comprehensive of medical billing and practice management, including electronic billing to insurance companies, electronic payments and remittance, patient statements, and claims management. Taken as a whole, this version of NightingaleEHR is the path forward for clients using our RidgeMark and Medrium products."

NightingaleEHR is already certified for Meaningful Use Stage 1 and certification for Meaningful Use Stage 2 is scheduled for June 2014. With the release of R5 the company will also begin ICD-10 testing with select clients during the summer.

"We are really excited about R5 and the continued success of the NightingaleEHR platform," continued Chebib. "Feedback from our pilot sites and early adopters has been extremely positive - especially around the product's intuitive and easy-to-use interface. We continue to put our energy behind NightingaleEHR and drive towards our own internal goal of 'one-company, one platform'."

About Nightingale
For more than a decade, Nightingale (TSX-V: NGH) has been delivering innovative cloud-based Electronic Health Record (EHR) and Practice Management solutions to healthcare organizations across the United States and Canada. Our goal is to uncomplicate the day-to-day challenges of healthcare providers. We achieve this by creating software that is truly intuitive—minimizing training and maximizing adoption. We believe so strongly in building easy-to-use software that we structured our entire product team around user-centric design. Our clients are benefiting from this focus through a well-supported and robust solution that presents a holistic view of a person's well-being in a simple, clean interface, so that the best health decisions can be made. Nightingale - One Patient. One Record. www.nightingalemd.com

Forward Looking Statement
This press release contains "forward-looking statements" respecting the issuance and cancellation of securities of the Company within the meaning of applicable Canadian securities legislation. Generally, forward-looking statements can be identified by the use of forward- looking terminology such as "plans", "expects" or "does not expect",  "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may" ,"could", "would", "might", "occur" or "be achieved". Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Nightingale to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: risks related to the speculative nature of the medical software industry, which is affected by numerous factors beyond Nightingale's control; the ability of Nightingale to successfully secure customer contracts and the timing of securing such contracts; the ability of Nightingale to complete and successfully integrate its acquisitions on an accretive basis, Nightingale's access to debt and capital facilities, including compliance with current debt arrangements; the existence of present and possible future government regulation; the significant competition that exists in the medical software industry; the early stage of Nightingale's business, and risks associated with early stage companies, including uncertainty of revenues, markets and profitability and the need to raise additional funding.  All material assumptions used in making forward-looking statements are based on management's knowledge of current business conditions and expectations of future business conditions and trends. Certain material factors or assumptions applied by management in making forward-looking statements, include without limitation, factors and assumptions regarding future trends in healthcare spending, economic conditions affecting Nightingale and North American economies; Nightingale's ability to continue to fund its business, rates of customer defaults, relationships with, and payments to lenders, as well as Nightingale's operating cost structure.

Although Nightingale has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Nightingale does not undertake to update any forward-looking statements that are incorporated by reference herein, except in accordance with applicable securities laws. Further information on Nightingale Informatix Corporation is available at www.sedar.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Nightingale Informatix Corporation

Media Inquiries
Brittany Quemby, Marketing Specialist
Nightingale Informatix Corporation
Tel: [phone]
[email protected]

Investor Inquiries
Marc Lakmaaker, Senior Account Executive
TMX Equicom
Tel: [phone] ext. 248
[email protected]